CLEAR CELL SARCOMA (CCS)
Clinical trials for CLEAR CELL SARCOMA (CCS) explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL SARCOMA (CCS) trials appear
Sign up with your email to follow new studies for CLEAR CELL SARCOMA (CCS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare sarcoma: targeted drug trial opens
Disease control Recruiting nowThis study tests a drug called tebentafusp in people with a rare and advanced type of cancer called clear cell sarcoma. Only patients with a specific genetic marker (HLA-A*02:01) can join. The goal is to see if the drug can stop the cancer from growing for at least 24 weeks. Abou…
Matched conditions: CLEAR CELL SARCOMA (CCS)
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New hope for rare cancer: targeted pill tested in advanced sarcoma
Disease control Recruiting nowThis phase 2 trial tests the drug vebreltinib in 30 people with advanced clear cell sarcoma, a rare cancer of the soft tissues. Participants take the drug as a capsule twice daily until the cancer worsens or side effects become too severe. The main goal is to see if the drug can …
Matched conditions: CLEAR CELL SARCOMA (CCS)
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC